Christopher Twelves
Impact in
- Oncology top 5%
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Surgical Treatments
- HER2/EGFR in Cancer Research
- Cancer Research top 10%
- Breast Cancer Treatment Studies
Papers in
- Oncology 29
- Cancer Treatment and Pharmacology 18
- Colorectal Cancer Treatments and Studies 8
- HER2/EGFR in Cancer Research 5
- Lung Cancer Research Studies 4
-
- Breast Cancer Treatment Studies 9
- Co-authors
- Helen Mackay (2 shared papers)John M.S. Bartlett (6 shared papers)Alison F. Munro (4 shared papers)Greg Yothers (4 shared papers)Daniel G. Haller (4 shared papers)Michael J. O’Connell (4 shared papers)Eric Van Cutsem (1 shared paper)Daniel J. Sargent (1 shared paper)
- Journals
- Journal of Clinical Oncology (13 papers)Cancer Research (4 papers)Breast Cancer Research (3 papers)Cancer Chemotherapy and Pharmacology (2 papers)Nature reviews. Cancer (2 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Christopher Twelves
54 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 104
- Oncology 552
- Cancer Research 225
- Genetics 110
- Geriatrics and Gerontology 22
- Molecular Biology 428
Countries citing papers authored by Christopher Twelves
This map shows the geographic impact of Christopher Twelves's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Twelves with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Twelves more than expected).
Fields of papers citing papers by Christopher Twelves
This network shows the impact of papers produced by Christopher Twelves. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Twelves. The network helps show where Christopher Twelves may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Twelves, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 310 | |
| 2 | 2013 | 159 | |
| 3 | 2006 | 131 | |
| 4 | 2016 | 124 | |
| 5 | 2009 | 55 | |
| 6 | 2013 | 54 | |
| 7 | 2015 | 50 | |
| 8 | 2014 | 46 | |
| 9 | 2011 | 44 | |
| 10 | The protein kinase C inhibitor CGP41251 suppresses cytokine release and extracellular signal-regulated kinase 2 expression in cancer patients. | 1999 | 41 |
| 11 | 2006 | 37 | |
| 12 | 2015 | 33 | |
| 13 | 2011 | 31 | |
| 14 | 2015 | 25 | |
| 15 | Phase I Cancer Clinical Trials: A Practical Guide | 2006 | 22 |
| 16 | 2011 | 21 | |
| 17 | 2016 | 20 | |
| 18 | 2013 | 20 | |
| 19 | Can capecitabine replace 5-FU/leucovorin in combination with oxaliplatin for the treatment of advanced colorectal cancer? | 2002 | 17 |
| 20 | 1992 | 16 |
About Christopher Twelves
Christopher Twelves is a scholar working on Oncology, Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 54 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (18 papers), Breast Cancer Treatment Studies (9 papers), Colorectal Cancer Treatments and Studies (8 papers), HER2/EGFR in Cancer Research (5 papers), Advanced Breast Cancer Therapies (5 papers), Lung Cancer Research Studies (4 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). The work is most often cited by research in Oncology (552 citations), Cancer Research (225 citations), Genetics (110 citations), Geriatrics and Gerontology (22 citations) and Molecular Biology (428 citations). Christopher Twelves has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Helen Mackay, John M.S. Bartlett, Alison F. Munro, Greg Yothers, Daniel G. Haller, Michael J. O’Connell, Eric Van Cutsem, Daniel J. Sargent, Nadine J. McCleary and Jeffrey A. Meyerhardt. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Breast Cancer Research, Cancer Chemotherapy and Pharmacology and Nature reviews. Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.